Aetna Reaches New 12-Month High at $84.67 (AET)
Shares of Aetna (NYSE:AET) reached a new 52-week high during mid-day trading on Thursday , Analyst Ratings.Net reports. The company traded as high as $84.67 and last traded at $84.49, with a volume of 1,876,501 shares traded. The stock had previously closed at $82.16.
A number of research firms have recently commented on AET. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Aetna in a research note on Wednesday. They now have a $92.00 price target on the stock, up previously from $85.00. Separately, analysts at Susquehanna raised their price target on shares of Aetna from $90.00 to $95.00 in a research note on Monday. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Aetna in a research note on Thursday, July 10th. They now have a $94.00 price target on the stock, up previously from $89.00. Six research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $82.06.
The stock’s 50-day moving average is $80.67 and its 200-day moving average is $73.90. The company has a market cap of $29.918 billion and a price-to-earnings ratio of 14.46.
Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.98 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.55 by $0.43. The company had revenue of $13.97 billion for the quarter, compared to the consensus estimate of $13.69 billion. During the same quarter last year, the company posted $1.50 earnings per share. Aetna’s revenue was up 46.9% compared to the same quarter last year. On average, analysts predict that Aetna will post $6.54 earnings per share for the current fiscal year.
Aetna Inc (NYSE:AET), is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.